($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP



The AICAR peptide vial has been shown to offer several significant benefits in laboratory research:

  • Enhancing the efficiency of energy conversion
  • Increasing the capacity for breaking down adipose tissue
  • Promoting efficient fat burning
  • Maintaining stability during a cardiac ischemic episode

Out of stock

First time customer gets 15% discount code = 1storder

AICA Ribonucleotide (AICAR) Pre Mixed Peptide Australia

AICAR Pre Mixed peptide, also known as 5-Aminoimidazole-4-carboxamide ribonucleotide, is an AMPK activator that can enter cells. AMPK is a crucial regulator of metabolism and is activated in times of low energy. By activating AMPK with AICAR, it simulates the effects of exercise in the body, leading to increased glucose absorption in muscle cells.

This peptide is essential for improving endurance and reducing stored fat. Australia Research has shown that AICAR can increase fat loss and promote the movement of fat stores into mitochondria, where they are burned for energy. It has also been found to activate metabolic genes and improve exercise endurance in both active and inactive animals.

AICAR has demonstrated the ability to reduce cell swelling and promote the healing of damaged tissues. Australia Human trials have shown that it can improve insulin sensitivity and sugar regulation in diabetic individuals, making it a valuable tool in the prevention and treatment of type II diabetes.

Furthermore, AICAR pre mixed peptide has been shown to protect against cardiac ischemic injury and improve myocardial protection during heart bypass surgery. It also acts to reduce inflammation by interfering with signaling molecules involved in immune response.

In conclusion, AICAR pre mixed peptide offers benefits such as tissue recovery, fat burning, muscle contraction, and reducing inflammation. Its impact on metabolism and overall health make it a promising area of scientific research.

AICAR Pre Mixed Peptide Benefits Australia

Enhancing muscle gains:

AICAR research peptides have been found to effectively increase muscle mass in the body, making them essential not only for muscle growth but also for maintaining muscle mass. Moreover, they have been shown to help prevent muscle loss commonly associated with the aging process.

Studies have indicated that AMPK plays a vital role in slowing down skeletal muscle wasting linked to aging. In experiments involving mice lacking this protein, scientists observed significantly more muscle weakness than expected.

These findings suggest that the AICAR compound may potentially be used as a treatment for muscle wastage diseases in the future. Furthermore, when combined with intense exercise, AICAR’s muscle growth effects are further enhanced.

Anti-Inflammatory Properties:

Recent Australia clinical trials have revealed the vital role of AICAR in cellular inflammation. AICAR is similar to metformin, a well-established diabetes medication known for its anti-inflammatory properties.

AICAR has been proven to provide protection against inflammatory conditions like asthma, colitis, hepatitis, and atherosclerosis. Animal studies have demonstrated that AICAR can decrease inflammation in cases of colitis.

Moreover, scientific research suggests that AICAR pre mixed peptide may serve as a mediator in the development of autoimmune diseases and various other inflammatory conditions.

Effects on Fertility:

The beneficial effects of AMPK activators, specifically AICAR, on sperm in cats, chickens, and goats have been demonstrated. These activators improve sperm motility, metabolism, and fertilizing ability. In mice, AICAR administered orally has a high bioavailability and few adverse effects.

Enhancement of Insulin Sensitivity:

AICAR, at both high and low doses, has been proven to effectively reduce inflammation in adipose tissue, which is the connective tissue responsible for storing energy as fat. Inflammation in fat is linked to a higher risk of insulin resistance, but when inflammation is reduced, glucose regulation improves. AICAR achieves its reduction in inflammation effects in fat tissue through various pathways involving SIRT1 and macrophages.

In an animal experiment conducted on obese monkeys, researchers observed weight loss and improved insulin sensitivity as a result of AICAR pre mixed peptide treatment. Additionally, various studies on AICAR have shown that both healthy and diabetic mice experience a decrease in inflammatory response in cases of metabolic disorders. AICAR has also been found to improve insulin sensitivity, lipid metabolism, energy regulation, and symptoms of inflammation.

Prevention of Cardiovascular Disease:

Australia Researchers conducted a study on the impact of AICAR on rabbit models with atherosclerosis, a condition closely connected to inflammation and heart disease. The findings revealed that when administered, AICAR pre mixed peptide effectively hindered the growth of vascular smooth muscle, leading to a reduction in complications associated with stents, both in the short and long term.

Moreover, the study suggests that activating AICAR can suppress immune responses related to atherosclerosis. This is significant because the accumulation of LDL, or “bad” cholesterol, stimulates the proliferation of macrophages, ultimately increasing the risk of heart attack. Therefore, AICAR pre mixed peptide shows promise in potentially slowing down the development and occurrence of heart disease and heart attacks.

Death of Cancer Cells:

The AICAR hormone peptide plays a multifaceted role in the growth of cancer. Research has demonstrated that under different conditions, it can either impede or accelerate the development of tumors.

The prolonged activation of the AMPK enzyme stimulates the demise of cancer cells by reducing their metabolic activity.

Australia Scientists are currently studying the effectiveness of AICAR when used together with other chemotherapeutic drugs. It is believed that a combination of AICAR and pre mixed peptide can potentially achieve the following benefits:

  • Reduce negative side effects
  • Improve the outlook for patients with tumors that are resistant to chemotherapy
  • Enable lower doses of these compounds to be used.

In addition, studies have shown that AICAR pre mixed peptide can induce programmed cell death in thyroid cancer cells by causing p21 accumulation. Researchers firmly believe that AICAR pre mixed peptide has the ability to inhibit the growth and survival of cancer cells in general.

There is also the option Australia to buy Aicar Nasal Spray or buy Aicar Peptide Vial.

Sequence: 5-Aminoimidazole-4-carboxamide ribonucleotide

Molecular Formula: C9H15N4O8P

Molecular Weight: 338.21 g/mol

Storage: Lyophilized peptides to be stored below -18°C


[1] https://www.ncbi.nlm.nih.gov/ pubmed/19853624

[2] https://pubmed.ncbi.nlm.nih.gov/ 20844264/

[3] https://pubmed.ncbi.nlm.nih.gov/ 22324445/

Disclaimer: We do not supply sarms or peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (direct-sarms.com) and provided through Direct Sarms are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.

All images are for display purposes only. The products you receive may differ slightly from the images. But the quality always remands as a premium product.

Pen instructions

All of our injection pens will release 0.5ml water every 60 dials.

We mix this product with 2ml water therefore to calculate what 1 dial on the pen will release you will need to divide the full amount of product (e.g. if the product has 5mg divide 5000mcgs) by the full amount of dials on the pen (240)